Lexeo Therapeutics, Inc.

LXEO

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001907108

SEC filings (opens in a new tab)

In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Lexeo Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of LXEO: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	139	3	141	+5
Shares	79.9M	4.99M	88.2M	+13.3M (+17.8%)
Value	$458.7M	$28.6M	$410.9M	−$19.2M (−4.5%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Lexeo Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to LXEO in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	3,954,691	$18.4M	0.01%
Trexquant Investment LP	314,891	$1.47M	0.01%
Hennion & Walsh Asset Management, Inc.	265,697	$1.24M	0.04%
Renaissance Technologies LLC	250,365	$1.17M	0.00%
Palumbo Wealth Management LLC	114,743	$534.1K	0.11%
Fisher Asset Management, LLC	114,322	$532.2K	0.00%
Walleye Capital LLC	73,868	$343.9K	0.00%
State of Wisconsin Investment Board	48,324	$224.9K	0.00%
Dynamic Technology Lab Private Ltd	32,651	$152.0K	0.03%
Verdad Advisers, LP	30,591	$142.4K	0.14%
Quantinno Capital Management LP	24,293	$113.1K	0.00%
Prelude Capital Management, LLC	22,500	$104.7K	0.01%
American Century Companies Inc	18,855	$87.8K	0.00%
Canada Pension Plan Investment Board	18,500	$86.1K	0.00%
Jain Global LLC	16,585	$77.2K	0.00%
Spark Investment Management LLC	15,000	$69.8K	0.14%
Prudential Financial Inc	11,585	$53.9K	0.00%
SG Americas Securities, LLC	10,555	$49.0K	0.00%
Tyche Wealth Partners LLC	10,000	$46.5K	0.01%
SRS Capital Advisors, Inc.	3,409	$15.9K	0.00%
Pacer Advisors, Inc.	1,128	$5.00K	0.00%
Chung Wu Investment Group, LLC	1,000	$4.66K	0.00%
UMA Financial Services, Inc.	203	$945	0.00%
Farther Finance Advisors, LLC	159	$740	0.00%
Rialto Wealth Management, LLC	134	$624	0.00%
Silver Grove Financial Group, Inc.	10	$47	0.00%
Clearstead Advisors, LLC	6	$28	0.00%

Sold out (22)

Institutions that held Lexeo Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of LXEO in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Point72 Asset Management, L.P.	1,680,449	$9.65M
Octagon Capital Advisors LP	1,100,000	$6.31M
Two Sigma Investments, LP	181,676	$1.04M
Y-Intercept (Hong Kong) Ltd	142,571	$818.4K
DRW Securities, LLC	47,988	$275.5K
Bleakley Financial Group, LLC	47,964	$275.3K
Susquehanna International Group, LLP	46,998	$269.8K
Gsa Capital Partners LLP	34,269	$197.0K
Panagora Asset Management Inc	34,297	$196.9K
Axq Capital, LP	26,119	$149.9K
Schonfeld Strategic Advisors LLC	24,221	$139.0K
Bridgeway Capital Management, LLC	13,400	$76.9K
E Fund Management Co., Ltd.	12,683	$72.8K
Virtu Financial LLC	11,901	$68.0K
Ethic Inc.	11,132	$63.9K
Larson Financial Group LLC	1,456	$8.36K
Simplex Trading, LLC	1,240	$7.12K
Advisor Group Holdings, Inc.	411	$2.36K
Bare Financial Services, Inc	80	$459
Caitong International Asset Management Co., Ltd	60	$344
Basecamp Wealth Advisors LLC	29	$166
MAI Capital Management	11	$64

Not filed for Q2 2026 yet (3)

Institutions that held Lexeo Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LXEO in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	4,976,429	$28.5M
CWM, LLC	18,317	$105.1K
Sunbelt Securities, Inc.	16	$92